Way, way higher. I know, cause I get those migraines at least twice a month, to the point where I end up vomiting. This bio market cap should sit around 300 million dollars until they get either a buyout or sales on that the migraine treatment. If we don't get an offering either tonight or by close of tomorrow, leads me to believe there is buyout in the works.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.